Last reviewed · How we verify

NCT05828199

The Effect of Intraoperative Infusion of Dexmedetomidine Versus Low Dose Ketamine

Status unknown Phase 1 Last updated 25 April 2023
What this trial tests

Phase 1 trial testing Ketamine Hydrochloride in Nasal Polyps in 80 participants. Status unknown.

Timeline
1 December 2022
Primary endpoint
1 December 2023
20 December 2023

Quick facts

Lead sponsorAl-Azhar University
PhasePhase 1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date1 December 2022
Primary completion1 December 2023
Estimated completion20 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 21 to 40, any sex, with Nasal Polyps or Nasal Septum, Irregular. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing between dexmedetomidine versus low dose ketamine infusion in patients undergoing nasal and paranasal sinus surgery as regard, intraoperative hemodynamic stability, blood loss, perioperative opioid requirements, Stress response evaluation through the measurement of serum level of cortisol, IL-6, blood glucose and CRP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ketamine Hydrochloride

Trials testing the same drug.

Other recruiting trials for Nasal Polyps

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05828199.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing